focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,306.00
Bid: 12,302.00
Ask: 12,306.00
Change: -58.00 (-0.47%)
Spread: 4.00 (0.033%)
Open: 12,358.00
High: 12,376.00
Low: 12,276.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: BofA Rates Rotork Buy, Weir Underperform

Thu, 17th Dec 2020 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

BANK OF AMERICA RESUMES SMITHS GROUP WITH 'UNDERPERFORM' - TARGET 1,200 PENCE

----------

RBC CUTS BUNZL PRICE TARGET TO 2,200 (2,300) PENCE - 'UNDERPERFORM'

----------

CREDIT SUISSE RAISES SEVERN TRENT PRICE TARGET TO 2,340 (2,300) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE RAISES SCHRODERS TO 'NEUTRAL' (UNDERPERFORM) - TARGET 3,100 (2,690) PENCE

----------

CREDIT SUISSE RAISES STANDARD LIFE ABERDEEN TARGET TO 250 (240) PENCE - 'UP'

----------

GOLDMAN SACHS RAISES J SAINSBURY PRICE TARGET TO 205 (200) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS WM MORRISON SUPERMARKETS PRICE TARGET TO 210 (215) PENCE - 'BUY'

----------

RBC RAISES POLYMETAL PRICE TARGET TO 2,450 (2,225) PENCE - 'OUTPERFORM'

----------

DZ BANK CUTS FAIR VALUE FOR GLAXOSMITHKLINE TO 1,700 PENCE

----------

DZ BANK CUTS FAIR VALUE FOR ASTRAZENECA TO 6,700 (7,300) PENCE - 'SELL'

----------

LIBERUM CUTS ASTRAZENECA PRICE TARGET TO 9,430 (9,770) PENCE - 'BUY'

----------

RBC CUTS FRESNILLO PRICE TARGET TO 1,100 (1,300) PENCE - 'SECTOR PERFORM'

----------

CITIGROUP RAISES GLENCORE PRICE TARGET TO 300 (270) PENCE - 'BUY'

----------

FTSE 250

----------

BANK OF AMERICA RESUMES ROTORK WITH 'BUY' - TARGET 350 PENCE

----------

BANK OF AMERICA RESUMES WEIR GROUP WITH 'UNDERPERFORM' - TARGET 1,500 PENCE

----------

MORGAN STANLEY RAISES WIZZ AIR PRICE TARGET TO 5,000 (4,200) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EASYJET PRICE TARGET TO 900 (800) PENCE - 'EQUAL-WEIGHT'

----------

BARCLAYS RAISES ELECTROCOMPONENTS TARGET TO 775 (766) PENCE - 'EQUAL WEIGHT'

----------

CREDIT SUISSE RAISES MAN GROUP TO 'OUTPERFORM' (NEUTRAL) - TARGET 150 (130) PENCE

----------

CREDIT SUISSE RAISES ASHMORE GROUP TARGET TO 390 (360) PENCE - 'UNDERPERFORM'

----------

CREDIT SUISSE RAISES JUPITER FUND PRICE TARGET TO 270 (250) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 490 (440) PENCE - 'OUTPERFORM'

----------

LIBERUM RAISES DIXONS CARPHONE PRICE TARGET TO 175 (150) PENCE - 'BUY'

----------

BARCLAYS RAISES DIXONS CARPHONE PRICE TARGET TO 145 (120) PENCE - 'OVERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

MORGAN STANLEY RAISES RYANAIR PRICE TARGET TO 18.00 (15.60) EUR - 'OVERWEIGHT'

----------

JEFFERIES RAISES SCAPA GROUP PRICE TARGET TO 210 (150) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.